Export 468 results:
[ Author(Desc)] Keyword Title Type Year
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
D. Bensamoun, Guignard, R., Furst, A. J., Derreumaux, A., Manera, V., Darcourt, J., Benoit, M., Robert, P. H., and David, R., Associations between Neuropsychiatric Symptoms and Cerebral Amyloid Deposition in Cognitively Impaired Elderly People., J Alzheimers Dis, vol. 49, no. 2, pp. 387-98, 2016.
G. Berge, Lauridsen, C., Sando, S. Botne, Holder, D. Joseph, Møller, I., Aasly, J. Olav, Bråthen, G., Savage, M. Josephine, and White, L. Rosemary, Effect of Tween-20 on Core Biomarkers Measured in Cerebrospinal Fluid from Patients with Alzheimer's Disease, Mild Cognitive Impairment, or Healthy Control Individuals., J Alzheimers Dis, vol. 49, no. 2, pp. 493-502, 2016.
M. Berger, Cooter, M., Roesler, A. S., Chung, S., Park, J., Modliszewski, J. L., VanDusen, K. W., J Thompson, W., Moseley, A., Devinney, M. J., Smani, S., Hall, A., Cai, V., Browndyke, J. N., Lutz, M. W., and Corcoran, D. L., APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid., J Alzheimers Dis, vol. 79, no. 2, pp. 511-530, 2021.
A. W. Bero, Yan, P., Roh, J. Hoon, Cirrito, J. R., Stewart, F. R., Raichle, M. E., Lee, J. - M., and Holtzman, D. M., Neuronal activity regulates the regional vulnerability to amyloid-β deposition., Nat Neurosci, vol. 14, no. 6, pp. 750-6, 2011.
M. Bertoux, de Souza, L. Cruz, O'Callaghan, C., Greve, A., Sarazin, M., Dubois, B., and Hornberger, M., Social Cognition Deficits: The Key to Discriminate Behavioral Variant Frontotemporal Dementia from Alzheimer's Disease Regardless of Amnesia?, J Alzheimers Dis, vol. 49, no. 4, pp. 1065-74, 2016.
M. A. Beydoun, Gamaldo, A. A., Beydoun, H. A., Shaked, D., Zonderman, A. B., and Eid, S. M., Trends, Predictors, and Outcomes of Healthcare Resources Used in Patients Hospitalized with Alzheimer's Disease with at Least One Procedure: The Nationwide Inpatient Sample., J Alzheimers Dis, vol. 57, no. 3, pp. 813-824, 2017.
C. Birkenbihl, Westwood, S., Shi, L., Nevado-Holgado, A., Westman, E., Lovestone, S., and Hofmann-Apitius, M., ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset., J Alzheimers Dis, vol. 79, no. 1, pp. 423-431, 2021.
C. M. Black, Fillit, H., Xie, L., Hu, X., M Kariburyo, F., Ambegaonkar, B. M., Baser, O., Yuce, H., and Khandker, R. K., Economic Burden, Mortality, and Institutionalization in Patients Newly Diagnosed with Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 185-193, 2018.
K. Blennow and Zetterberg, H., The Past and the Future of Alzheimer's Disease Fluid Biomarkers., J Alzheimers Dis, vol. 62, no. 3, pp. 1125-1140, 2018.
V. Boccardi, Ruggiero, C., Patriti, A., and Marano, L., Diagnostic Assessment and Management of Dysphagia in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 4, pp. 947-55, 2016.
M. Bocchetta, Mega, A., Bernardi, L., Di Maria, E., Benussi, L., Binetti, G., Borroni, B., Colao, R., Di Fede, G., Fostinelli, S., Galimberti, D., Gennarelli, M., Ghidoni, R., Piaceri, I., Pievani, M., Porteri, C., Redaelli, V., Rossi, G., Suardi, S., Babiloni, C., Scarpini, E., Tagliavini, F., Padovani, A., Nacmias, B., Sorbi, S., Frisoni, G. B., and Bruni, A. C., Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol., J Alzheimers Dis, vol. 51, no. 1, pp. 277-91, 2016.
M. Bolós, Llorens-Martín, M., Jurado-Arjona, J., Hernández, F., Rábano, A., and Avila, J., Direct Evidence of Internalization of Tau by Microglia In Vitro and In Vivo., J Alzheimers Dis, vol. 50, no. 1, pp. 77-87, 2016.
V. Bonet-Costa, Herranz-Pérez, V., Blanco-Gandía, M. C., Mas-Bargues, C., Inglés, M., Garcia-Tarraga, P., Rodriguez-Arias, M., Miñarro, J., Borras, C., Garcia-Verdugo, J. Manuel, and Viña, J., Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 701-11, 2016.
G. Boström, Freyhult, E., Virhammar, J., Alcolea, D., Tumani, H., Otto, M., Brundin, R. - M., Kilander, L., Löwenmark, M., Giedraitis, V., Lleo, A., von Arnim, C. A. F., Kultima, K., and Ingelsson, M., Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid., J Alzheimers Dis, vol. 81, no. 2, pp. 629-640, 2021.
B. O. A. Botchway, Moore, M. K., Akinleye, F. O., Iyer, I. C., and Fang, M., Nutrition: Review on the Possible Treatment for Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 3, pp. 867-883, 2018.
O. Bousiges, Cretin, B., Lavaux, T., Philippi, N., Jung, B., Hezard, S., Heitz, C., Demuynck, C., Gabel, A., Martin-Hunyadi, C., and Blanc, F., Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies., J Alzheimers Dis, vol. 51, no. 4, pp. 1069-83, 2016.
C. Boutoleau-Bretonnière, Pouclet-Courtemanche, H., Gillet, A., Bernard, A., Deruet, A. Laure, Gouraud, I., Mazoue, A., Lamy, E., Rocher, L., Kapogiannis, D., and Haj, M. El, The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis., J Alzheimers Dis, vol. 76, no. 1, pp. 41-47, 2020.
W. H. Bouvy, Kuijf, H. J., Zwanenburg, J. J. M., Koek, H. L., L Kappelle, J., Luijten, P. R., M Ikram, K., and Biessels, G. Jan, Abnormalities of Cerebral Deep Medullary Veins on 7 Tesla MRI in Amnestic Mild Cognitive Impairment and Early Alzheimer's Disease: A Pilot Study., J Alzheimers Dis, vol. 57, no. 3, pp. 705-710, 2017.
H. Braak, Thal, D. R., Ghebremedhin, E., and Del Tredici, K., Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years., J Neuropathol Exp Neurol, vol. 70, no. 11, pp. 960-9, 2011.
D. Brici, Götz, J., and Nisbet, R. M., A Novel Antibody Targeting Tau Phosphorylated at Serine 235 Detects Neurofibrillary Tangles., J Alzheimers Dis, vol. 61, no. 3, pp. 899-905, 2018.
P. Buchhave, Minthon, L., Zetterberg, H., Wallin, A. K., Blennow, K., and Hansson, O., Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia., Arch Gen Psychiatry, vol. 69, no. 1, pp. 98-106, 2012.
A. S. Bukhbinder, Ling, Y., Hasan, O., Jiang, X., Kim, Y., Phelps, K. N., Schmandt, R. E., Amran, A., Coburn, R., Ramesh, S., Xiao, Q., and Schulz, P. E., Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching., J Alzheimers Dis, vol. 88, no. 3, pp. 1061-1074, 2022.
M. A. Burguillos, Deierborg, T., Kavanagh, E., Persson, A., Hajji, N., Garcia-Quintanilla, A., Cano, J., Brundin, P., Englund, E., Venero, J. L., and Joseph, B., Caspase signalling controls microglia activation and neurotoxicity., Nature, vol. 472, no. 7343, pp. 319-24, 2011.
C. M. Burns, Kaszniak, A. W., Chen, K., Lee, W., Bandy, D. J., Caselli, R. J., and Reiman, E. M., Longitudinal Changes in Serum Glucose Levels are Associated with Metabolic Changes in Alzheimer's Disease Related Brain Regions., J Alzheimers Dis, vol. 62, no. 2, pp. 833-840, 2018.